Valuation: Guangzhou Wondfo Biotech Co.,Ltd

Capitalization 10.42B 1.45B 1.24B 1.16B 1.08B 1.99B 125B 2.22B 13.96B 5.29B 58.47B 5.45B 5.34B 214B P/E ratio 2025 *
16.4x
P/E ratio 2026 * 14.1x
Enterprise value 10.42B 1.45B 1.24B 1.16B 1.08B 1.99B 125B 2.22B 13.96B 5.29B 58.47B 5.45B 5.34B 214B EV / Sales 2025 *
3.04x
EV / Sales 2026 * 2.67x
Free-Float
54.9%
Yield 2025 *
2.11%
Yield 2026 * 2.48%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.28%
1 week+1.73%
Current month+2.11%
1 month+2.59%
3 months+2.98%
6 months-1.54%
Current year-2.72%
More quotes
1 week 21.46
Extreme 21.46
22.02
1 month 20.4
Extreme 20.4
22.02
Current year 19.26
Extreme 19.26
26.48
1 year 19.2
Extreme 19.2
31.5
3 years 19.2
Extreme 19.2
50.65
5 years 19.2
Extreme 19.2
83.6
10 years 12.18
Extreme 12.1773
85.38
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 18/01/2023
Director of Finance/CFO 48 10/04/2012
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 62 31/12/1991
Chairman 62 20/07/2016
Director/Board Member 66 10/04/2012
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.28%+1.73%-13.49%-45.99% 1.45B
+0.25%+0.34%+24.78%+15.56% 16.45B
+4.56%+4.49% - - 7.37B
-0.96%+0.46%+60.19%+3.56% 6.23B
-0.72%-0.65%-10.06%+23.57% 6.05B
0.00%+1.39%-10.51%-30.05% 5.71B
+2.15%+4.89%-32.70%+22.31% 5.63B
+0.40%+0.24%-13.48%-19.75% 3.02B
+0.96%+1.79%-7.43%-40.83% 2.27B
+0.41%+1.94%-18.78%-40.34% 2.08B
Average +0.73%+1.44%-2.39%-12.44% 5.63B
Weighted average by Cap. +0.78%+1.35%+7.39%+1.47%
See all sector performances

Financials

2025 *2026 *
Net sales 3.43B 479M 410M 382M 356M 655M 41.18B 730M 4.6B 1.74B 19.27B 1.8B 1.76B 70.64B 3.9B 545M 466M 434M 405M 745M 46.83B 830M 5.23B 1.98B 21.91B 2.04B 2B 80.35B
Net income 641M 89.42M 76.54M 71.26M 66.49M 122M 7.69B 136M 859M 326M 3.6B 335M 328M 13.19B 789M 110M 94.22M 87.73M 81.86M 151M 9.47B 168M 1.06B 401M 4.43B 413M 404M 16.24B
Net Debt - -
More financial data * Estimated data
Logo Guangzhou Wondfo Biotech Co.,Ltd
Guangzhou Wondfo Biotech Co Ltd is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, and other fields.
Employees
3,197
More about the company
Date Price Change Volume
14/07/25 21.80 ¥ +0.28% 4,790,240
11/07/25 21.74 ¥ +0.46% 6,911,769
10/07/25 21.64 ¥ +0.09% 5,430,022
09/07/25 21.62 ¥ +0.19% 7,998,141
08/07/25 21.58 ¥ +0.70% 4,229,974

End-of-day quote Shenzhen S.E., July 13, 2025

More quotes
Trading Rating
Investor Rating
ESG MSCI
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
21.80CNY
Average target price
25.08CNY
Spread / Average Target
+15.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300482 Stock